Product
Supplier
Encyclopedia
Inquiry
Eloralintide buy - large image1
Eloralintide buy - image1
Eloralintide buy - image2

Eloralintide

KOSHER ISO COA 49 Inquiries

Unit Price: Get Latest Price
CAS No.:

2883634-40-8

Grade:

Industrial Grade

Content:

90%

Port:

Shanghai

Brand:

Sichuan Jisheng

Packaging:

1g/bag

Price valid (until):

2028-01-01

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Copper Peptide / GHK-Cu,Myristoyl Pentapeptide-17,SYN-COLL / Palmitoyl Tripeptide-5

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Sichuan Jisheng Biopharmaceutical Co., Ltd.(JSJ), established in 2015, is located in the high-tech industrial zone of Leshan city, Sichuan province, covering an area of 60,000  square meters. We are a professional enterprise for research and development, production and sale of biological fermentation enzymes transform products, natural plant extracts, food additives custom peptides, cosmetic raw materials (cosmetic peptide & amino acid derivatives), etc.. JSJ cooperates closely with Sichuan Jisheng Health Food Co., Ltd. and Sichuan Elegbacepharm Co., Ltd, which got Food Production License, Drug Production License, and the new edition GMP certification. We have invested more than 180 million RMB for a number of GMP workshop production lines and the modernizing production facilities and advanced detecting instruments.

    We have set up innovation center, all of the staff in this center are professionals including 6 professors and doctors and 9 graduate students. We have built strategic partnership with Chengdu Institute Chinese Academy of Sciences, Leshan Normal University and Southwest University of Science and Technology. 

    Since established, we have built stable business relationships with many food companies, healthfood companies, cosmetic manufacturers, domestic pharmaceutical companies, R&D institutes, exporters and importers. JSJ enjoys high reputation internationally and is your most reliable partner. 

    Items Specifications






    ECHEMI Editorial Reference

    Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

    Certificates

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Copper Peptide / GHK-Cu,Myristoyl Pentapeptide-17,SYN-COLL / Palmitoyl Tripeptide-5

    Location:

    No.3 Jianye Avenue,High-Tech Zone,LeShan,Sichuan,China

    Average lead Time:

    10

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    301-500

    Year of Establishment:

    2015

    Sichuan Jisheng Biopharmaceutical Co., Ltd.(JSJ), established in 2015, is located in the high-tech industrial zone of Leshan city, Sichuan province, covering an area of 60,000 square meters. We are a professional enterprise for research and development, production and sale of biological fermentation enzymes transform products, natural plant extracts, food additives custom peptides, cosmetic raw materials (cosmetic peptide & amino acid derivatives), etc.. JSJ cooperates closely with Sichuan Jisheng Health Food Co., Ltd. and Sichuan Elegbacepharm Co., Ltd, which got Food Production License, Drug Production License, and the new edition GMP certification. We have invested more than 180 million RMB for a number of GMP workshop production lines and the modernizing production facilities and advanced detecting instruments.

    We have set up innovation center, all of the staff in this center are professionals including 6 professors and doctors and 9 graduate students. We have built strategic partnership with Chengdu Institute Chinese Academy of Sciences, Leshan Normal University and Southwest University of Science and Technology.
    Since established, we have built stable business relationships with many food companies, healthfood companies, cosmetic manufacturers, domestic pharmaceutical companies, R&D institutes, exporters and importers. JSJ enjoys high reputation internationally and is your most reliable partner.

  • Inquiry History
    49 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    Italy

    Eloralintide

    5 PCS Aug 19, 2026
    United States

    eloralintide

    2 PCS Aug 2, 2026
    United States

    eloralintide

    30 MG Jul 28, 2026
    United States

    Elora

    32 G Jul 27, 2026
    United States

    Eloralintide

    1 G Jul 13, 2026
    United States

    Eloralintide

    10 PCS Jul 11, 2026
    Singapore

    Eloralintide

    1 G Jul 1, 2026
    United States

    eloralintide

    50 MT Jun 12, 2026
    United States

    Eloralintide and Retatrutide

    2 MT Jun 8, 2026
    United States

    Eloralintide

    5 PCS May 27, 2026
    South Korea

    eloralintide

    2 G Feb 24, 2026
    United States

    Eloralintide

    1 G Feb 20, 2026
    United States

    ELORALINTIDE

    10 MG Feb 19, 2026
    United States

    Eloralintide

    100 PCS Feb 15, 2026
    United Kingdom

    Eloralintide

    10  Dec 28, 2025
    United States

    Eloralintide

    600 MG Aug 20, 2026
    Bahamas

    Eloralintide

    10 MT Aug 4, 2026
    United States

    Eloralintide

    2 PCS Aug 2, 2026
    United States

    Eloralintide

    10 PCS Jul 30, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.